BIOMAT Database Logo BIOMAT Database Logo

The glucagon receptor antagonist desHis1Pro4Glu9-glucagon(Lys12PAL) alters alpha-cell turnover and lineage in mice, but does not cause alpha-cell hyperplasia. 2023

Ryan Lafferty, and Neil Tanday, and Vaibhav Dubey, and Aimee Coulter-Parkhill, and Karthick Vishal, and Charlotte Moffett, and Finbarr O'Harte, and Peter R Flatt, and Nigel Irwin
Centre for Diabetes, Ulster University, Coleraine, Northern Ireland, UK.

Glucagon receptor (GCGR) antagonism elicits antihyperglycemic effects in rodents and humans. The present study investigates whether the well characterised peptide-based GCGR antagonist, desHis1Pro4Glu9-glucagon (Lys12PAL), alters alpha-cell turnover or identity in mice. Multiple low-dose streptozotocin (STZ) treated (50 mg/kg bw, 5 days) transgenic GluCreERT2;ROSA26-eYFP mice were employed. STZ mice received twice daily administration of saline vehicle or desHis1Pro4Glu9-glucagon (Lys12PAL), at low- or high-dose (25 and 100 nmol/kg, respectively) for 11 days. No GCGR antagonist induced changes in food or fluid intake, body weight or glucose homeostasis were observed. As expected, STZ dramatically reduced (P < 0.001) islet numbers and increased (P < 0.01) alpha-to beta-cell ratio, which was linked to elevated (P < 0.05) levels of beta-cell apoptosis. Whilst treatment with desHis1Pro4Glu9-glucagon (Lys12PAL) decreased (P < 0.05-P < 0.001) alpha- and beta-cell areas, it also helped restore the classic rodent islet alpha-cell mantle in STZ mice. Interestingly, low-dose desHis1Pro4Glu9-glucagon (Lys12PAL) increased (P < 0.05) alpha-cell apoptosis rates whilst high dose decreased (p < 0.05) this parameter. This difference reflects substantially increased (P < 0.001) alpha-to beta-cell transdifferentiation following high dose desHis1Pro4Glu9-glucagon (Lys12PAL) treatment, which was not fully manifest with low-dose therapy. Taken together, the present study indicates that peptidic GCGR antagonists can positively influence alpha-cell turnover and lineage in identity in multiple low-dose STZ mice, but that such effects are dose-related.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018027 Receptors, Glucagon Cell surface receptors that bind glucagon with high affinity and trigger intracellular changes which influence the behavior of cells. Activation of glucagon receptors causes a variety of effects; the best understood is the initiation of a complex enzymatic cascade in the liver which ultimately increases the availability of glucose to body organs. Glucagon Receptors,Glucagon Receptor,Receptor, Glucagon

Related Publications

Ryan Lafferty, and Neil Tanday, and Vaibhav Dubey, and Aimee Coulter-Parkhill, and Karthick Vishal, and Charlotte Moffett, and Finbarr O'Harte, and Peter R Flatt, and Nigel Irwin
Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.
February 2003, Proceedings of the National Academy of Sciences of the United States of America,
Ryan Lafferty, and Neil Tanday, and Vaibhav Dubey, and Aimee Coulter-Parkhill, and Karthick Vishal, and Charlotte Moffett, and Finbarr O'Harte, and Peter R Flatt, and Nigel Irwin
Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition.
March 2017, Proceedings of the National Academy of Sciences of the United States of America,
Ryan Lafferty, and Neil Tanday, and Vaibhav Dubey, and Aimee Coulter-Parkhill, and Karthick Vishal, and Charlotte Moffett, and Finbarr O'Harte, and Peter R Flatt, and Nigel Irwin
An anti-insulin serum, but not a glucagon antagonist, alters glycemia in fed chickens.
April 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Ryan Lafferty, and Neil Tanday, and Vaibhav Dubey, and Aimee Coulter-Parkhill, and Karthick Vishal, and Charlotte Moffett, and Finbarr O'Harte, and Peter R Flatt, and Nigel Irwin
γ-aminobutyric acid modulates α-cell hyperplasia but not β-cell regeneration induced by glucagon receptor antagonism in type 1 diabetic mice.
January 2023, Acta diabetologica,
Ryan Lafferty, and Neil Tanday, and Vaibhav Dubey, and Aimee Coulter-Parkhill, and Karthick Vishal, and Charlotte Moffett, and Finbarr O'Harte, and Peter R Flatt, and Nigel Irwin
The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
November 2008, Endocrinology,
Ryan Lafferty, and Neil Tanday, and Vaibhav Dubey, and Aimee Coulter-Parkhill, and Karthick Vishal, and Charlotte Moffett, and Finbarr O'Harte, and Peter R Flatt, and Nigel Irwin
Massive formation of square array junctions dramatically alters cell shape but does not cause lens opacity in the cav1-KO mice.
August 2014, Experimental eye research,
Ryan Lafferty, and Neil Tanday, and Vaibhav Dubey, and Aimee Coulter-Parkhill, and Karthick Vishal, and Charlotte Moffett, and Finbarr O'Harte, and Peter R Flatt, and Nigel Irwin
Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool.
September 2011, Gastroenterology,
Ryan Lafferty, and Neil Tanday, and Vaibhav Dubey, and Aimee Coulter-Parkhill, and Karthick Vishal, and Charlotte Moffett, and Finbarr O'Harte, and Peter R Flatt, and Nigel Irwin
CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE(-/-) mice.
February 2010, Atherosclerosis,
Ryan Lafferty, and Neil Tanday, and Vaibhav Dubey, and Aimee Coulter-Parkhill, and Karthick Vishal, and Charlotte Moffett, and Finbarr O'Harte, and Peter R Flatt, and Nigel Irwin
Perinatal SSRI exposure permanently alters cerebral serotonin receptor mRNA in mice but does not impact adult behaviors.
June 2018, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
Ryan Lafferty, and Neil Tanday, and Vaibhav Dubey, and Aimee Coulter-Parkhill, and Karthick Vishal, and Charlotte Moffett, and Finbarr O'Harte, and Peter R Flatt, and Nigel Irwin
Glucagon receptor gene deletion in insulin knockout mice modestly reduces blood glucose and ketones but does not promote survival.
August 2016, Molecular metabolism,
Copied contents to your clipboard!